Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02498925 · ClinicalTrials.gov registry record · NA

Examining Reward-Related Predictors and Mechanisms of Change in BA Treatment for Anhedonic Adolescents

A NA study, sponsored by Mclean Hospital.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT02498925 is a NA study that has completed, run by Mclean Hospital. The registered enrollment target is 80 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02498925, a NA study, has completed, sponsored by Mclean Hospital.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

The prevalence of major depressive disorder (MDD) is relatively low in childhood (i.e., 1-3%), but increases substantially during adolescence. By the age of 18, approximately 15% of adolescents will have experienced at least one episode of MDD. A growing body of research implicates abnormalities in reward circuitry as playing a critical role in the development and maintenance of depressive symptoms in adolescents. Importantly, these reward-circuitry abnormalities have been linked to anhedonia (i.e., decreased pleasure or blunted reactivity to rewarding stimuli). Behavioral Activation (BA) represents a promising - and relatively simple to deliver - nonpharmacologic intervention for adolescent depression, which has been shown to be at least as effective as Cognitive Behavioral Therapy (CBT) with regards to symptom reduction and lowering the risk of relapse in adult samples. More recently, promising data have emerged from the application of BA to depressed adolescents. BA can be conceptualized as a treatment directly targeting anhedonia. More specifically, BA targets anhedonia through behavioral change strategies aimed at gradually increasing patients' exposure to and engagement with rewarding stimuli and positively reinforcing experiences. Given this treatment focus, BA may be particularly beneficial for adolescents struggling with relatively elevated levels of anhedonic symptoms. Accordingly, the present study will examine the role of anhedonia and reward functioning in predicting treatment response in BA. In addition, analyses will be conducted examining the reward-related neural and behavioral mechanisms underlying anhedonic symptom improvement in BA.

Interventions

  • BEHAVIORAL Behavioral Activation

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2015-12
Est. Completion 2023-05
Phase NA

Sponsor

Mclean Hospital

140 total trials

What the Registry Record Tells You About NCT02498925

The ClinicalTrials.gov registry entry for NCT02498925 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Behavioral Activation is the first listed.

NCT02498925 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02498925 about?

NCT02498925 is a clinical study titled "Examining Reward-Related Predictors and Mechanisms of Change in BA Treatment for Anhedonic Adolescents". The prevalence of major depressive disorder (MDD) is relatively low in childhood (i.e., 1-3%), but increases substantially during adolescence. By the age of 18, approximately 15% of adolescents will have experienced at least one episode of MDD. A growing body of research implicates abnormalities in ...

What is the current status of trial NCT02498925?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2015-12. Estimated completion is 2023-05.

What interventions are being tested in trial NCT02498925?

The interventions under investigation include: Behavioral Activation (BEHAVIORAL).

Who is sponsoring clinical trial NCT02498925?

This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.